These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 11513170

  • 1. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
    Froehlich F, Gonvers JJ, Wietlisbach V, Burnand B, Hildebrand P, Schneider C, Saraga E, Beglinger C, Vader JP, Eradication in Dyspepsia (ERADYS) Study Group.
    Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170
    [Abstract] [Full Text] [Related]

  • 2. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
    Blum AL, Talley NJ, O'Moráin C, van Zanten SV, Labenz J, Stolte M, Louw JA, Stubberöd A, Theodórs A, Sundin M, Bolling-Sternevald E, Junghard O.
    N Engl J Med; 1998 Dec 24; 339(26):1875-81. PubMed ID: 9862942
    [Abstract] [Full Text] [Related]

  • 3. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
    Talley NJ, Vakil N, Ballard ED, Fennerty MB.
    N Engl J Med; 1999 Oct 07; 341(15):1106-11. PubMed ID: 10511608
    [Abstract] [Full Text] [Related]

  • 4. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
    Koskenpato J, Farkkilä M, Sipponen P.
    Am J Gastroenterol; 2001 Oct 07; 96(10):2866-72. PubMed ID: 11693319
    [Abstract] [Full Text] [Related]

  • 5. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
    Veldhuyzen van Zanten S, Fedorak RN, Lambert J, Cohen L, Vanjaka A.
    Am J Gastroenterol; 2003 Sep 07; 98(9):1963-9. PubMed ID: 14499772
    [Abstract] [Full Text] [Related]

  • 6. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E.
    Turk J Gastroenterol; 2005 Mar 07; 16(1):29-33. PubMed ID: 16252185
    [Abstract] [Full Text] [Related]

  • 7. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B, Melzer E, Keller N, Bar-Meir S.
    Isr Med Assoc J; 2001 Mar 07; 3(3):163-5. PubMed ID: 11303370
    [Abstract] [Full Text] [Related]

  • 8. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
    Gisbert JP, Cruzado AI, Garcia-Gravalos R, Pajares JM.
    Hepatogastroenterology; 2004 Mar 07; 51(55):303-8. PubMed ID: 15011890
    [Abstract] [Full Text] [Related]

  • 9. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S, Japan Helicobacter pylori Eradication Study Group.
    J Gastroenterol; 2003 Mar 07; 38(4):339-47. PubMed ID: 12743773
    [Abstract] [Full Text] [Related]

  • 10. Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial.
    Jarbol DE, Kragstrup J, Stovring H, Havelund T, Schaffalitzky de Muckadell OB.
    Am J Gastroenterol; 2006 Jun 07; 101(6):1200-8. PubMed ID: 16771937
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of the symptomatology and quality of life in functional dyspepsia before and after Helicobacter pylori eradication treatment].
    Ladrón de Guevara L, Peña-Alfaro NG, Padilla L, Lichtinger A, Figueroa S, Shapiro I, Rubinstein M, Di Silvio M.
    Rev Gastroenterol Mex; 2004 Jun 07; 69(4):203-8. PubMed ID: 15765971
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].
    Lamouliatte H, Perie F, Joubert-Collin M.
    Gastroenterol Clin Biol; 2000 May 07; 24(5):495-500. PubMed ID: 10891736
    [Abstract] [Full Text] [Related]

  • 13. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ, O'Connell S, Schnell T, Chejfec G, Seidel J, Sonnenberg A.
    Am J Gastroenterol; 2001 May 07; 96(5):1390-5. PubMed ID: 11374672
    [Abstract] [Full Text] [Related]

  • 14. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.
    McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, Kelman A, Penny C, Knill-Jones R, Hilditch T.
    N Engl J Med; 1998 Dec 24; 339(26):1869-74. PubMed ID: 9862941
    [Abstract] [Full Text] [Related]

  • 15. Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
    Oderda G, Marinello D, Lerro P, Kuvidi M, de'Angelis GL, Ferzetti A, Cucchiara S, Franco MT, Romano C, Strisciuglio P, Pensabene L.
    Helicobacter; 2004 Aug 24; 9(4):293-301. PubMed ID: 15270743
    [Abstract] [Full Text] [Related]

  • 16. Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?
    Maconi G, Parente F, Russo A, Vago L, Imbesi V, Bianchi Porro G.
    Am J Gastroenterol; 2001 Feb 24; 96(2):359-66. PubMed ID: 11232676
    [Abstract] [Full Text] [Related]

  • 17. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
    Koskenpato J, Färkkilä M, Sipponen P.
    Scand J Gastroenterol; 2002 Jul 24; 37(7):778-84. PubMed ID: 12190090
    [Abstract] [Full Text] [Related]

  • 18. Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial.
    Ott EA, Mazzoleni LE, Edelweiss MI, Sander GB, Wortmann AC, Theil AL, Somm G, Cartell A, Rivero LF, Uchôa DM, Francesconi CF, Prolla JC.
    Aliment Pharmacol Ther; 2005 May 15; 21(10):1231-9. PubMed ID: 15882244
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
    Cindoruk M, Erkan G, Karakan T, Dursun A, Unal S.
    Helicobacter; 2007 Aug 15; 12(4):309-16. PubMed ID: 17669103
    [Abstract] [Full Text] [Related]

  • 20. Failure of Helicobacter pylori eradication: is poor compliance the main cause?
    Wermeille J, Cunningham M, Dederding JP, Girard L, Baumann R, Zelger G, Buri P, Metry JM, Sitavanc R, Gallaz L, Merki H, Godin N.
    Gastroenterol Clin Biol; 2002 Mar 15; 26(3):216-9. PubMed ID: 11981460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.